Top

Published in:

01-02-2004 | Original Article

Keratin immunohistochemistry in renal cell carcinoma subtypes and renal oncocytomas: a systematic analysis of 233 tumors

Authors: Cord Langner, Beate J. Wegscheider, Manfred Ratschek, Luigi Schips, Richard Zigeuner

Published in: Virchows Archiv | Issue 2/2004

Abstract

Keratin immunohistochemistry represents a widely applied differential diagnostic tool in surgical pathology. To investigate the value of keratin subtyping for the diagnosis among histological subtypes of renal cell carcinoma and oncocytomas, we performed a detailed immunohistochemical study, applying 22 different monoclonal keratin antibodies on a large series of 233 renal tumors [125 conventional, 22 chromophobe, and 20 papillary (12 type-1, 8 type-2 tumors) cancers and 66 oncocytomas] using a tissue microarray technique. Immunoreactivity for keratin 7, 8, 18, and 19 was present in all tumor entities, albeit in varying quantities. With antibodies directed against keratins 8 and 18, oncocytomas showed a distinct perinuclear and punctate dot-like pattern, which was not observed in renal cancer specimens. The only tumors showing immunoreactivity for keratin 20 were two type-2 papillary cancers. All other monospecific keratin antibodies yielded consistently negative results. Overall, in contrast to some recent publications, keratin subtyping generally appeared to be of additional value only for the differentiation of renal epithelial tumors. Hence, with respect to differential diagnostic value, Hale’s colloidal iron stain and vimentin immunostaining are still the most useful tools in renal tumor pathology.

Amin MB, Amin MB, Tamboli P, Javidan J, Stricker H, De-Peralta Venturina M, Deshpande A, Menon M (2002) Prognostic impact of histologic subtyping of adult renal epithelial neoplasms. An experience of 405 cases. Am J Surg Pathol 26:281–291CrossRefPubMed

Bonsib SM, Bray C (1991) Cytokeratin-containing globular filamentous bodies in renal oncocytomas. Ultrastruct Pathol 15:521–529PubMed

Bonsib SM, Bromley C, Lager DJ (1991) Renal oncocytoma: diagnostic utility of cytokeratin-containing globular filamentous bodies. Mod Pathol 4:16–23PubMed

Cao Y, Karsten U, Zerban H, Bannasch P (2000) Expression of MUC1, Thomsen-Friedenreich-related antigens, and cytokeratin 19 in human renal cell carcinomas and tubular clear cell lesions. Virchows Arch 436:119–126PubMed

Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML (2003) Comparisons of outcome and prognostic features among histological subtypes of renal cell carcinoma. Am J Surg Pathol 27:612–624CrossRefPubMed

Chu PG, Weiss LM (2001) Cytokeratin 14 immunoreactivity distinguishes oncocytic tumour from its renal mimics: an immunohistochemical study of 63 cases. Histopathology 39:455–462CrossRefPubMed

Chu PG, Weiss LM (2002) Keratin expression in human tissues and neoplasms. Histopathology 40:403–439CrossRefPubMed

Chu PG, Wu E, Weiss LM (2000) Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 13:962–972PubMed

Delahunt B, Eble JN (1997) Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 10:537–544PubMed

10.

Gatalica Z, Kovatich A, Miettinen M (1995) Consistent expression of keratin 7 in papillary renal-cell carcinoma. J Urol Pathol 3:205–211

11.

Han AC, Duszak R Jr (1999) Coexpression of cytokeratins 7 and 20 confirms urothelial carcinoma presenting as an intrarenal tumor. Cancer 86:2327–2330CrossRefPubMed

12.

Kim K, Kim S (2002) Immunohistochemical profile of common epithelial neoplasms arising in the kidney. Appl Immunohistochem Mol Morphol 10:332–338CrossRefPubMed

13.

Klein MJ, Valensi QJ (1976) Proximal tubular adenomas of the kidney with so-called oncocytic features. A clinicopathologic study of 13 cases of a rarely reported neoplasm. Cancer 38:906–914PubMed

14.

Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844–847PubMed

15.

Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, Eble JN, Fleming S, Ljungberg B, Medeiros LJ, Moch H, Reuter VE, Ritz E, Roos G, Schmidt D, Srigley JR, Storkel S, van den Berg E, Zbar B (1997) The Heidelberg classification of renal cell tumors. J Pathol 183:131–133CrossRefPubMed

16.

Kuroda N, Toi M, Hiroi M, Enzan H (2003) Review of chromophobe renal cell carcinomas with focus on clinical and pathobiological aspects. Histol Histopathol 18:165–171PubMed

17.

Leroy X, Moukassa D, Copin MC, Saint F, Mazeman E, Gosselin B (2000) Utility of cytokeratin 7 for distinguishing chromophobe renal cell carcinoma from renal oncocytoma. Eur Urol 37:484–487CrossRefPubMed

18.

Ljungberg B, Alamdari FI, Stenling R, Roos G (1999) Prognostic significance of the Heidelberg classification of renal cell carcinoma. Eur Urol 36:565–569CrossRefPubMed

19.

Mathers ME, Pollock AM, Marsh C, O’Donnell M (2002) Cytokeratin 7: a useful adjunct in the diagnosis of chromophobe renal cell carcinoma. Histopathology 40:563–567CrossRefPubMed

20.

Méjean A, Oudard S, Thiounn N (2003) Prognostic factors of renal cell carcinoma. J Urol 169:821–827CrossRefPubMed

21.

Miettinen M (1995) Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol 8:384–388PubMed

22.

Moch H, Gasser T, Amin MB, Torhorst J, Sauter G, Mihatsch MJ (2000) Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer 89:604–614PubMed

23.

Moll R (1994) Cytokeratins in the histological diagnosis of malignant tumors. Int J Biol Markers 9:63–69PubMed

24.

Moll R (1998) Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors. Subcell Biochem 31:205–262PubMed

25.

Mostofi FK, Davis CJ (eds) (1998) Histological typing of kidney tumors. International histological classification of tumors, 2nd edn. Springer, Berlin Heidelberg New York

26.

O’Hara BJ, Paetau A, Miettinen M (1998) Keratin subsets and monoclonal antibody HBME-1 in chordoma: immunohistochemical differential diagnosis between tumors simulating chordoma. Hum Pathol 29:119–126PubMed

27.

Perez-Ordonez B, Hamed G, Campbell S, Erlandson RA, Russo P, Gaudin PB, Reuter VE (1997) Renal oncocytoma: a clinicopathologic study of 70 cases. Am J Surg Pathol 21:871–883CrossRefPubMed

28.

Pitz S, Moll R, Störkel S, Thoenes W (1987) Expression of intermediate filament proteins in subtypes of renal cell carcinomas and in renal oncocytomas. Distinction of two classes of renal cell tumors. Lab Invest 56:642–653PubMed

29.

Renshaw AA (2002) Subclassification of renal cell neoplasms: an update for the practising pathologist. Histopathology 41:283–300CrossRefPubMed

30.

Renshaw AA, Zhang H, Corless CL, Fletcher JA, Pins MR (1997) Solid variants of papillary (chromophil) renal cell carcinoma: clinicopathologic and genetic features. Am J Surg Pathol 21:1203–1209CrossRefPubMed

31.

Satoh S, Tatsumi H, Suzuki K, Taniguchi N (1992) Distribution of manganese superoxide dismutase in rat stomach: application of triton X-100 and suppression of endogenous streptavidin binding activity. J Histochem Cytochem 40:1157–1163PubMed

32.

Scarpatetti M, Tsybrovskyy O, Popper HH (2002) Cytokeratin typing as an aid in the differential diagnosis of primary versus metastatic lung carcinomas, and comparison with normal lung. Virchows Arch 440:70–76CrossRefPubMed

33.

Stopyra GA, Warhol MJ, Multhaupt HA (2001) Cytokeratin 20 immunoreactivity in renal oncocytomas. J Histochem Cytochem 49:919–920PubMed

34.

Störkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, Darson M, Delahunt B, Iczkowski K (1997) Classification of renal cell carcinoma. Cancer 80:987–991CrossRefPubMed

35.

Taki A, Nakatani Y, Misugi K, Yao M, Nagashima Y (1999) Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases. Mod Pathol 12:310–317PubMed

36.

Tallini G (1998) Oncocytic tumours. Virchows Arch 433:5–12CrossRefPubMed

37.

Wang NP, Zee S, Zarbo RJ, Bacchi CE, Gown AM (1995) Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 3:99–107

38.

Wu SL, Kothari P, Wheeler TM, Reese T, Connelly JH (2002) Cytokeratins 7 and 20 immunoreactivity in chromophobe renal cell carcinomas and renal oncocytomas. Mod Pathol 15:712–717PubMed

Title: Keratin immunohistochemistry in renal cell carcinoma subtypes and renal oncocytomas: a systematic analysis of 233 tumors
Authors: Cord Langner
Beate J. Wegscheider
Manfred Ratschek
Luigi Schips
Richard Zigeuner
Publication date: 01-02-2004
Publisher: Springer-Verlag
Published in: Virchows Archiv / Issue 2/2004
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-003-0948-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Keratin immunohistochemistry in renal cell carcinoma subtypes and renal oncocytomas: a systematic analysis of 233 tumors

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2004

Expression of insulin-like growth factor mitogenic signals in adult soft-tissue sarcomas: significant correlation with malignant potential

Immunohistochemical staining of protein kinase C isozymes (βII and δ) is helpful to distinguish reactive follicles from follicular colonization of MALT lymphoma

Metaplastic mammary carcinoma with osteoclast-like giant cells: identical point mutation of p53 gene only identified in both the intraductal and sarcomatous components

Oligoclonal T-cell populations in an inflammatory pseudotumor of the pancreas possibly related to autoimmune pancreatitis: an immunohistochemical and molecular analysis

Microsatellite instability analysis and/or immunostaining for the diagnosis of hereditary nonpolyposis colorectal cancer?

New manuscript submission and processing: Virchows Archiv goes online!